0000000000640505

AUTHOR

Marlene Hechtner

showing 22 related works from this author

Incidence of heterotopic ossification in minimally invasive short-stem THA using the modified anterolateral approach.

2017

Introduction Heterotopic ossification (HO) is known to be a common complication after total hip arthroplasty (THA). The minimal invasive (MIS) modified anterolateral approach has become popular in combination with a short stem. We analysed the incidence of HO following short-stem THA using this approach in combination with a postoperative administration of nonsteroidal anti-inflammatory drugs (NSAIDs). Materials and methods 216 short stems were implanted in 162 patients. NSAIDs were administered for 2 weeks after surgery in 154 patients (95.1%). Standardised pre- and postoperative radiographic imaging was done at 2-year follow-up. HO was analysed according to the Brooker classification. Inf…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentArthroplasty Replacement HipOsteoarthritisProsthesis DesignRisk AssessmentOsteoarthritis HipBody Mass IndexCohort Studies03 medical and health sciences0302 clinical medicineSex FactorsmedicineHumansMinimally Invasive Surgical ProceduresOrthopedics and Sports Medicine030212 general & internal medicineAgedPain MeasurementRetrospective StudiesHip surgeryPostoperative Care030222 orthopedicsShort stemOssificationbusiness.industryIncidence (epidemiology)IncidenceOssification HeterotopicAnti-Inflammatory Agents Non-SteroidalAge FactorsRecovery of FunctionMiddle Agedmedicine.diseaseArthroplastySurgeryPatient SatisfactionSurgeryHeterotopic ossificationFemaleHip Prosthesismedicine.symptombusinessComplicationHip international : the journal of clinical and experimental research on hip pathology and therapy
researchProduct

Compliance with patient-reported outcome assessment in glioma patients: predictors for drop out

2017

Abstract Background Patient-reported outcomes are of high importance in clinical neuro-oncology. However, assessment is still suboptimal. We aimed at exploring factors associated with the probability for a) drop out of study and b) death during follow-up. Methods Patients were assessed twice during follow-up visits scheduled within 3 to 5 months of each other by using 3 validated patient-reported outcome measures (t1: first assessment, t2: second assessment). As “death” was seen as a competing risk for drop out, univariate competing risk Cox regression models were applied to explore factors associated with dropping out (age, gender, WHO grade, living situation, recurrent surgery, Karnofsky …

medicine.medical_specialtyMotor dysfunctionKarnofsky Performance Statusbusiness.industryProportional hazards modelMedicine (miscellaneous)Original Articlesmedicine.diseasehumanities03 medical and health sciences0302 clinical medicinePhysical functioning030220 oncology & carcinogenesisDrop outInternal medicineGliomamedicinePhysical therapyDistress ThermometerPatient-reported outcomebusiness030217 neurology & neurosurgeryNeuro-Oncology Practice
researchProduct

Endovascular treatment of head and neck arteriovenous malformations: long-term angiographic and quality of life results.

2016

AimTo present the long-term angiographic and subjective results of patients with head and neck arteriovenous malformations (HNAVMs) after endovascular treatment.MethodsWe retrospectively analyzed the medical files of 14 patients with HNAVM who were treated between 2000 and 2014. The treatment of choice was a transarterial superselective microcatheter-based approach followed by embolization using liquid embolic agents. The patients were asked to answer a quality of life questionnaire about the following symptoms before and after treatment: pain, functional impairment, cosmetic deformity, impairment in daily life, and bleeding.ResultsComplete or >90% closure of the AVM was achieved in 6 of…

AdultIntracranial Arteriovenous MalformationsMalemedicine.medical_specialtymedicine.medical_treatmentArteriovenous fistula030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineQuality of lifeSurveys and QuestionnairesmedicineHumansEmbolizationAgedRetrospective Studiesmedicine.diagnostic_testbusiness.industryVascular malformationEndovascular ProceduresInfantArteriovenous malformationRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseEmbolization TherapeuticSurgeryCerebral AngiographyTreatment OutcomeArteriovenous FistulaQuality of LifeIntracranial Arteriovenous MalformationsSurgeryFemaleNeurology (clinical)Radiologybusiness030217 neurology & neurosurgeryCerebral angiographyJournal of neurointerventional surgery
researchProduct

Craniofacial venous malformations treated by percutaneous sclerotherapy using polidocanol: a single-center experience.

2018

Background Percutaneous therapy with various sclerosants is an established treatment of venous malformations in general. We investigated the safety and effectiveness of polidocanol in the craniofacial region. Purpose To present and evaluate our subjective and objective mid- and long-term results of patients with craniofacial venous malformations (CFVM) after percutaneous sclerotherapy using polidocanol. Material and Methods Twenty patients with CFVM treated by percutaneous sclerotherapy were followed up and asked to fill in a questionnaire comparing levels of the following CFVM-related symptoms before and after treatment: pain; functional impairment; cosmetic deformities; and impairment in …

medicine.medical_specialtyPercutaneousVascular Malformationsmedicine.medical_treatmentPolidocanol030204 cardiovascular system & hematologySingle Center030218 nuclear medicine & medical imagingPolidocanol03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesSclerotherapymedicineSclerotherapyHumansRadiology Nuclear Medicine and imagingCraniofacialRetrospective StudiesRadiological and Ultrasound Technologybusiness.industryHead neckGeneral MedicineSclerosing SolutionsSurgeryTreatment OutcomeFacebusinessNeckmedicine.drugActa radiologica (Stockholm, Sweden : 1987)
researchProduct

Early Impact of Pulmonary Fractionated Stereotactic Body Radiotherapy on Quality of Life:Benefit for Patients With Low Initial Scores (STRIPE Trial)

2019

Abstract Introduction Quality of life (QoL) of comorbid patients with pulmonary malignancies is a key issue in considering fractionated stereotactic body radiotherapy (SBRT) indication. This study investigates the early impact of SBRT on QoL. Methods One hundred patients with pulmonary lesions were treated with SBRT from February 2011 to December 2014 within the prospective, monocenter, phase II STRIPE trial. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core module (EORTC QLQ-C30) and the QLQ-LC13 lung cancer-specific questionnaire were used to evaluate QoL before, 2 and 7 weeks after SBRT, then every 3 months for 2 years. We report on the ana…

Male0301 basic medicinePulmonary and Respiratory Medicinemedicine.medical_specialtyLung NeoplasmsHealth StatusRadiosurgeryEmotional function03 medical and health sciences0302 clinical medicineQuality of lifeSurveys and QuestionnairesInternal medicinemedicineHumansProspective StudiesAgedLungbusiness.industryCancerPrognosismedicine.diseasehumanitiesKarnofsky index030104 developmental biologymedicine.anatomical_structureOncology030220 oncology & carcinogenesisCharlson comorbidity indexQuality of LifeFemaleDose Fractionation RadiationbusinessStereotactic body radiotherapyFollow-Up StudiesJournal of Thoracic Oncology
researchProduct

Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observat…

2020

Abstract: Background The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Lung Cancer 13 (QLQ-LC13) assesses quality of life (QOL) in patients with lung cancer and was the first EORTC module developed for use in international clinical trials. Since its publication in 1994, major treatment advances with possible effects on QOL have occurred. These changes called for an update of the module and its international psychometric validation. We aimed to investigate the scale structure and psychometric properties of the updated lung cancer module, QLQ-LC29, in patients with lung cancer. Methods This international, observational field study was done in…

Malemedicine.medical_specialtyPsychometricsPsychometrics10255 Clinic for Thoracic SurgeryQUESTIONNAIRE610 Medicine & health03 medical and health sciences0302 clinical medicineCronbach's alphaQuality of lifeCarcinoma Non-Small-Cell LungSurveys and QuestionnairesMedicine and Health SciencesmedicineHumans030212 general & internal medicineVALIDITYLung cancerAgedLanguagebusiness.industryQLQ-C30CancerMiddle Agedmedicine.diseaseSmall Cell Lung CarcinomaTRENDShumanitiesConfirmatory factor analysisClinical trialOncology030220 oncology & carcinogenesisQuality of LifePhysical therapyFemaleObservational study2730 OncologyHuman medicinebusinessCLINICAL-TRIALS
researchProduct

Quality of Life in NSCLC Survivors - A Multicenter Cross-Sectional Study.

2019

The objective was to assess quality of life (QoL) in lung cancer survivors, compare it to the general population, and identify factors associated with global QoL, physical functioning, emotional functioning, fatigue, pain, and dyspnea.Data from NSCLC patients who had survived 1 year or longer after diagnosis were collected cross-sectionally in a multicenter study. QoL was assessed with the European Organisation for the Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ)-C30 and the lung cancer module QLQ-LC13 across different clinical subgroups and compared to age- and sex-standardized general population reference values. Multivariable linear regression analyses wer…

0301 basic medicinePulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyLung NeoplasmsCross-sectional studyPopulation03 medical and health sciences0302 clinical medicineQuality of lifeInternal medicineCarcinoma Non-Small-Cell LungSurveys and QuestionnairesMedicineHumansSurvivorsLung cancereducationAgedAged 80 and overeducation.field_of_studybusiness.industryCancerMiddle Agedmedicine.diseasePrognosisCombined Modality TherapyhumanitiesSurvival Rate030104 developmental biologyCross-Sectional StudiesOncologyMulticenter study030220 oncology & carcinogenesisQuality of LifePatient-reported outcomeFemaleActive treatmentbusinessFollow-Up StudiesJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
researchProduct

Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries.

2013

Little is known about the relationship between specific subtypes of treatment-associated motor complications and different domains of health-related Quality of Life (QoL) in patients with Parkinson's disease (PD). Larger studies that investigate these aspects within a cross-cultural setting are scarce.To assess QoL and its association with on-off fluctuations, peak-dose dyskinesias, biphasic dyskinesias, and off-dystonias in PD patients from five European countries.Data from 817 PD patients were collected cross-sectionally in France, Germany, Italy, Spain, and the UK. QoL was measured with the generic EuroQoL 5-Dimension questionnaire (EQ-5D) and the disease-specific Parkinson's Disease Que…

AdultMalemedicine.medical_specialtyParkinson's diseaseNeurologyDiseaseAntiparkinson AgentsQuality of life (healthcare)Surveys and QuestionnairesActivities of Daily LivingMedicineHumansIn patientPsychiatryAgedAged 80 and overDyskinesiasbusiness.industryParkinson DiseaseMiddle Agedmedicine.diseaseEuropeNeurologyDyskinesiaQuality of LifeFemaleNeurology (clinical)Geriatrics and Gerontologymedicine.symptombusinessParkinsonismrelated disorders
researchProduct

Frequency of a positive family history of colorectal cancer in general practice: a cross-sectional study.

2016

BACKGROUND Evidence on the frequency of a positive family history of colorectal cancer (CRC) among individuals aged <55 years is lacking. General practice setting might be well suited for the identification of individuals in this above-average risk group. OBJECTIVE To determine the frequency of a reported positive family history of CRC among patients aged 40 to 54 years in a general practice setting. METHODS We conducted a cross-sectional study in 21 general practices in Germany. Patients aged 40 to 54 years were identified by means of the practice software and interviewed by health care assistants using a standardized four-item questionnaire. Outcome was occurrence of a positive family his…

OncologyAdultMalemedicine.medical_specialtyAdenomaCross-sectional studyColorectal cancerGeneral PracticeColonic PolypsUterine Cervical NeoplasmsNuclear Family03 medical and health sciences0302 clinical medicineStomach NeoplasmsInternal medicineGermanymedicinePrevalenceHumans030212 general & internal medicineFirst-degree relativesFamily historyMedical History TakingOvarian NeoplasmsUrethral Neoplasmsbusiness.industryCancerMiddle Agedmedicine.diseasedigestive system diseasesConfidence intervalKidney NeoplasmsPedigreeCross-Sectional StudiesGeneral practice030211 gastroenterology & hepatologyFemaleFamily PracticebusinessColorectal NeoplasmsFamily practice
researchProduct

What is the best time for psychosocial counselling from the perspective of cancer patients and their relatives? : A multi-centre qualitative study

2021

medicine.medical_specialtybusiness.industryPerspective (graphical)610 MedizinCancermedicine.diseasePsychiatry and Mental healthClinical PsychologyFamily medicine610 Medical sciencesmedicineMulti centrebusinessPsychosocialApplied PsychologyQualitative research
researchProduct

Endovascular therapy for vasospasm after aneurysmatic subarachnoid hemorrhage

2016

Balloon angioplasty and/or selective intra-arterial vasodilator therapies are treatment options in patients with vasospasm after subarachnoid hemorrhage (SAH). We analyzed the effect of balloon angioplasty and/or selective intra-arterial vasodilator therapy in our patients.Twenty-six patients (vasodilation group, VDT) were treated with intra-arterial nimodipine. The balloon angioplasty with nimodiopine-group (BAP-N group) comprised 21 patients. The primary endpoint of this study was successful angiographic vessel dilation in vasospastic vessels after balloon angioplasty, together with nimodipine (BAP-N group), compared to intra-arterial vasodilator therapy (VDT group) with nimodipine alone.…

AdultMalemedicine.medical_specialtySubarachnoid hemorrhageVasodilator Agentsmedicine.medical_treatmentCerebral arteriesVasodilationBalloon030218 nuclear medicine & medical imaging03 medical and health sciencesPostoperative Complications0302 clinical medicineInternal medicineAngioplastymedicineClinical endpointHumansVasospasm IntracranialNimodipineAgedRetrospective Studiesbusiness.industryEndovascular ProceduresVasospasmGeneral MedicineCerebral ArteriesMiddle AgedSubarachnoid Hemorrhagemedicine.diseaseTreatment OutcomeInjections Intra-ArterialAnesthesiaCardiologyFemaleNimodipineSurgeryPatient SafetyNeurology (clinical)businessAngioplasty Balloon030217 neurology & neurosurgerymedicine.drugBritish Journal of Neurosurgery
researchProduct

Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study.

2015

Background Although the risk of developing colorectal cancer (CRC) is 2-4 times higher in case of a positive family history, risk-adapted screening programs for family members related to CRC- patients do not exist in the German health care system. CRC screening recommendations for persons under 55 years of age that have a family predisposition have been published in several guidelines. The primary aim of this study is to determine the frequency of positive family history of CRC (1st degree relatives with CRC) among 40–54 year old persons in a general practitioner (GP) setting in Germany. Secondary aims are to detect the frequency of occurrence of colorectal neoplasms (CRC and advanced adeno…

Research designAdenomaAdultCancer Researchmedicine.medical_specialtyCross-sectional studyGeneral PracticeRisk AssessmentStudy ProtocolInformed consentGermanyHealth careGeneticsmedicineHumansddc:610Family historyEarly Detection of CancerPreventive healthcareGynecologyFamily HealthPhysician-Patient Relationsbusiness.industryColonoscopyMiddle AgedHealth SurveysClinical trialCross-Sectional StudiesOncologyResearch DesignFamily medicineOccult BloodPreventive MedicinebusinessRisk assessmentColorectal NeoplasmsBMC cancer
researchProduct

Quality of life after pulmonary stereotactic fractionated radiotherapy (SBRT): Results of the phase II STRIPE trial.

2019

Preserving health related quality of life (HRQOL) plays an important role in considering stereotactic body fractionated radiotherapy (SBRT). The prospective monocenter phase II STRIPE trial investigated long-term HRQOL after SBRT, efficacy and toxicity.Patients with ≤2 pulmonary lesions ≤5 cm were treated with 4DPET/CT-based SBRT (3 × 12.5 Gy or risk-adapted 5 × 7 Gy, to 60% isodose). Follow up (FU) was performed 2 and 7 weeks after SBRT, then 3-monthly for 2 years with assessment of response (primary endpoint: 2-year cumulative incidence of local progression (LP); secondary endpoints: local progression free survival (LPFS), overall survival (OS) and toxicity (CTCAE)). Impact of predefined …

Oncologymedicine.medical_specialtyLung NeoplasmsFractionated radiotherapyRadiosurgery030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineQuality of lifeInternal medicinemedicineClinical endpointHumansRadiology Nuclear Medicine and imagingCumulative incidenceProgression-free survivalProspective StudiesLung cancerHealth related quality of lifebusiness.industryHematologymedicine.diseasehumanitiesRegimenOncology030220 oncology & carcinogenesisQuality of LifeDose Fractionation RadiationbusinessRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
researchProduct

Biomarker discovery study of inflammatory proteins for colorectal cancer early detection demonstrated importance of screening setting validation

2018

Abstract Objectives Most studies identifying inflammatory markers for early detection of colorectal cancer (CRC) were conducted using clinically manifest cases. We aimed to identify circulating inflammatory biomarkers for early detection of CRC and validate them in both a clinical setting and a true screening setting. Study Design and Setting A total of 92 inflammatory proteins were quantified in baseline plasma samples from individuals clinically diagnosed with CRC and neoplasm-free controls matched on age and sex (training set). A multimarker panel was selected and evaluated in samples from another clinical setting (validation set C) and a screening setting (validation set S). Results In …

AdultMale0301 basic medicineOncologymedicine.medical_specialtyEpidemiologyColorectal cancerEarly detectionSensitivity and Specificity03 medical and health sciences0302 clinical medicineInternal medicineBiomarkers TumorHumansMedicineProspective StudiesBiomarker discoveryEarly Detection of CancerAgedAged 80 and overTraining setColorectal cancer early detectionbusiness.industryMiddle AgedCancer Early Detectionmedicine.diseaseInflammatory biomarkers030104 developmental biologyArea Under Curve030220 oncology & carcinogenesisBiomarker (medicine)FemaleColorectal NeoplasmsbusinessAlgorithmsJournal of Clinical Epidemiology
researchProduct

Long-term quality of life in inoperable non-small cell lung cancer patients treated with conventionally fractionated compared to hyperfractionated ac…

2017

Abstract Background and purpose To evaluate the quality of life (QoL) of patients with inoperable non-small cell lung cancer treated with conventionally fractionated radiotherapy (CF) vs. continuous hyperfractionated accelerated radiotherapy weekend-less (CHARTWEL). Material and methods The largest monocentric subgroup of the phase III CHARTWEL trial was analyzed up to three years after randomization. QoL was assessed with the European Organization for Research and Treatment of Cancer QoL Core Questionnaire (QLQ-C30) and lung cancer module (QLQ-LC13) and compared using linear mixed models. QoL interrelations with recurrence, metastasis, and death were explored by multi-state modeling. Resul…

MaleOncologymedicine.medical_specialtyLung NeoplasmsRandomizationMetastasis03 medical and health sciences0302 clinical medicineQuality of lifeCarcinoma Non-Small-Cell LungInternal medicinemedicineHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineLung cancerHyperfractionated accelerated radiotherapyAgedAged 80 and overbusiness.industryCancerHematologyMiddle Agedmedicine.diseaseDysphagiahumanitiesTreatment OutcomeOncology030220 oncology & carcinogenesisQuality of LifeFemaleDose Fractionation RadiationNon small cellNeoplasm Recurrence Localmedicine.symptombusinessRadiotherapy and Oncology
researchProduct

Psychological distress in lung cancer survivors at least 1 year after diagnosis-Results of a German multicenter cross-sectional study.

2017

AdultMaleLung NeoplasmsCross-sectional studyHealth StatusExperimental and Cognitive PsychologyAnxietyGerman03 medical and health sciences0302 clinical medicineCancer SurvivorsSurvivorship curveGermanySurveys and QuestionnairesmedicineHumans030212 general & internal medicineLung cancerDepression (differential diagnoses)Agedbusiness.industryDepressionPsychological distressMiddle Agedmedicine.diseaselanguage.human_languagePsychiatry and Mental healthDistressCross-Sectional StudiesOncology030220 oncology & carcinogenesislanguageAnxietyFemalemedicine.symptombusinessStress PsychologicalClinical psychologyPsycho-oncology
researchProduct

Assessing psychological and supportive care needs in glioma patients - feasibility study on the use of the Supportive Care Needs Survey Short Form (S…

2016

Neuro-oncological patients experience high symptom and psychosocial burden. The aim was to test feasibility and practicability of the Supportive Care Needs Survey Short Form (SCNS-SF34-G) and the SCNS-Screening Tool (SCNS-ST9) to assess supportive care needs of neuro-oncological patients in clinical routine. A total of 173 patients, most with a primary diagnosis of high-grade glioma (81%), were assessed first using SCNS-SF34-G in comparison to two well-established patient-reported outcome measures, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQC30 + QLQ-BN20) and Distress Thermometer (DT). In a follow-up assessment, SCNS-ST9 was used …

AdultMalemedicine.medical_specialtyPsychometricsYoung Adult03 medical and health sciences0302 clinical medicineQuality of life (healthcare)GliomamedicineHumansScreening toolAgedHealth Services Needs and DemandBrain Neoplasmsbusiness.industrySocial SupportGliomaMiddle Agedmedicine.diseaseTest (assessment)Clinical PracticeDistressOncologyHealth Care Surveys030220 oncology & carcinogenesisNeeds assessmentPhysical therapyFeasibility StudiesFemalebusinessPsychosocialNeeds Assessment030217 neurology & neurosurgeryEuropean Journal of Cancer Care
researchProduct

Additional file 5: of Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-se…

2015

Questionnaire 4. (PDF 225Â kb)

researchProduct

Additional file 3: of Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-se…

2015

Questionnaire 2. (PDF 256Â kb)

researchProduct

Additional file 2: of Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-se…

2015

Questionnaire 1. (PDF 286Â kb)

researchProduct

Additional file 1: of Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-se…

2015

Screening list. (PDF 85Â kb)

researchProduct

Additional file 4: of Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-se…

2015

Questionnaire 3. (PDF 244Â kb)

researchProduct